Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Cancer

Figure 2

From: CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer

Figure 2

Representative images of patient who experienced local relapse. a. Axial MR T2 weighted image before treatment. Tumor extends to right pelvic wall. b. Axial CT image at the first session of intracavitary brachytherapy (ICBT). Tumor still extends to right pelvic wall after 40 Gy of whole pelvic EBRT. Black arrow represents isodose line of 60 Gy (EQD2) and white arrow HR-CTV at the time of brachytherapy. c. Axial MR T2 weighted image 3 months after completion of chemoradiotherapy. Persistent disease was found in right parametrium.

Back to article page